Their struggles since the start of 2015 contrasts with a climb of more than 45% for the overall S&P 500 as well as with a more modest 11% gain for the NYSE Arca Pharmaceutical index of U.S. and …
More GRAPHIC-Mylan stock boost follows long share struggles for company, generics industry Videos